Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study Comparing a New hMG Formulation (hMG-IBSA) to a Reference Product (Menopur®) in Patients Undergoing Ovarian Stimulation for in Vitro Fertilisation (IVF)

NCT01312766 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.

NCT NCT01312766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01312766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study Comparing a New hMG Formulation (hMG-IBSA) to a Reference Product (Menopur®) in Patients Undergoing Ovarian Stimulation for in Vitro Fertilisation (IVF)
Lead sponsor
IBSA Institut Biochimique SA
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2013
Enrollment
270 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infertility